{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:51:37Z","timestamp":1790434297888,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93109C00051"],"award-info":[{"award-number":["75N93109C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93109C00051"],"award-info":[{"award-number":["75N93109C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93109C00051"],"award-info":[{"award-number":["75N93109C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93109C00051"],"award-info":[{"award-number":["75N93109C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93109C00051"],"award-info":[{"award-number":["75N93109C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-56496-4","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T06:28:31Z","timestamp":1738477711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genes"],"prefix":"10.1038","volume":"16","author":[{"given":"Ting-Hui","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Chun David","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Fern\u00e1ndez-Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3402-2609","authenticated-orcid":false,"given":"Julianna","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-3740","authenticated-orcid":false,"given":"Xueyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4025-2646","authenticated-orcid":false,"given":"Wenli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7566-3536","authenticated-orcid":false,"given":"Jenna J.","family":"Guthmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-1245","authenticated-orcid":false,"given":"Patrick C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-3769","authenticated-orcid":false,"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6469-2419","authenticated-orcid":false,"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"key":"56496_CR1","unstructured":"World Health Organization. Influenza (Seasonal). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal) (3 October 2023)."},{"key":"56496_CR2","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.jmb.2017.06.015","volume":"429","author":"NC Wu","year":"2017","unstructured":"Wu, N. C. & Wilson, I. A. A perspective on the structural and functional constraints for immune evasion: insights from influenza virus. J. Mol. Biol. 429, 2694\u20132709 (2017).","journal-title":"J. Mol. Biol."},{"key":"56496_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0140-6736(97)11212-0","volume":"351","author":"EC Claas","year":"1998","unstructured":"Claas, E. C. et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351, 472\u2013477 (1998).","journal-title":"Lancet"},{"key":"56496_CR4","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","volume":"368","author":"R Gao","year":"2013","unstructured":"Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med 368, 1888\u20131897 (2013).","journal-title":"N. Engl. J. Med"},{"key":"56496_CR5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0140-6736(14)60111-2","volume":"383","author":"H Chen","year":"2014","unstructured":"Chen, H. et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. Lancet 383, 714\u2013721 (2014).","journal-title":"Lancet"},{"key":"56496_CR6","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMc2405371","volume":"390","author":"TM Uyeki","year":"2024","unstructured":"Uyeki, T. M. et al. Highly pathogenic avian influenza A(H5N1) virus infection in a dairy farm worker. N. Engl. J. Med 390, 2028\u20132029 (2024).","journal-title":"N. Engl. J. Med"},{"key":"56496_CR7","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1126\/science.adt0180","volume":"386","author":"TH Lin","year":"2024","unstructured":"Lin, T. H. et al. A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors. Science 386, 1128\u20131134 (2024).","journal-title":"Science"},{"key":"56496_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","volume":"325","author":"RJ Garten","year":"2009","unstructured":"Garten, R. J. et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197\u2013201 (2009).","journal-title":"Science"},{"key":"56496_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","volume":"22","author":"Y Wu","year":"2014","unstructured":"Wu, Y., Wu, Y., Tefsen, B., Shi, Y. & Gao, G. F. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol 22, 183\u2013191 (2014).","journal-title":"Trends Microbiol"},{"key":"56496_CR10","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1073\/pnas.1116200109","volume":"109","author":"S Tong","year":"2012","unstructured":"Tong, S. et al. A distinct lineage of influenza A virus from bats. Proc. Natl Acad. Sci. USA 109, 4269\u20134274 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56496_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2225645","volume":"12","author":"S Fereidouni","year":"2023","unstructured":"Fereidouni, S. et al. Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses. Emerg. Microbes Infect. 12, 2225645 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"56496_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.chom.2024.05.018","volume":"32","author":"U Karakus","year":"2024","unstructured":"Karakus, U. et al. H19 influenza A virus exhibits species-specific MHC class II receptor usage. Cell Host Microbe 32, 1089\u20131102.e10 (2024).","journal-title":"Cell Host Microbe"},{"key":"56496_CR13","doi-asserted-by":"publisher","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","volume":"9","author":"S Tong","year":"2013","unstructured":"Tong, S. et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 9, e1003657 (2013).","journal-title":"PLoS Pathog."},{"key":"56496_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41594-018-0025-9","volume":"25","author":"NC Wu","year":"2018","unstructured":"Wu, N. C. & Wilson, I. A. Structural insights into the design of novel anti-influenza therapies. Nat. Struct. Mol. Biol. 25, 115\u2013121 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"56496_CR15","doi-asserted-by":"publisher","first-page":"a038778","DOI":"10.1101\/cshperspect.a038778","volume":"10","author":"NC Wu","year":"2020","unstructured":"Wu, N. C. & Wilson, I. A. Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb. Perspect. Med 10, a038778 (2020).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"56496_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","volume":"27","author":"R Nachbagauer","year":"2021","unstructured":"Nachbagauer, R. et al. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. Nat. Med 27, 106\u2013114 (2021).","journal-title":"Nat. Med"},{"key":"56496_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","volume":"20","author":"DI Bernstein","year":"2020","unstructured":"Bernstein, D. I. et al. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. Lancet Infect. Dis. 20, 80\u201391 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"56496_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41591-021-01636-8","volume":"28","author":"SF Andrews","year":"2022","unstructured":"Andrews, S. F. et al. A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination. Nat. Med 28, 373\u2013382 (2022).","journal-title":"Nat. Med"},{"key":"56496_CR19","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.aac7263","volume":"349","author":"A Impagliazzo","year":"2015","unstructured":"Impagliazzo, A. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349, 1301\u20131306 (2015).","journal-title":"Science"},{"key":"56496_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","volume":"14","author":"F Krammer","year":"2015","unstructured":"Krammer, F. & Palese, P. Advances in the development of influenza virus vaccines. Nat. Rev. Drug Discov. 14, 167\u2013182 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"56496_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","volume":"324","author":"DC Ekiert","year":"2009","unstructured":"Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246\u2013251 (2009).","journal-title":"Science"},{"key":"56496_CR22","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1073\/pnas.0801367105","volume":"105","author":"AK Kashyap","year":"2008","unstructured":"Kashyap, A. K. et al. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc. Natl Acad. Sci. USA 105, 5986\u20135991 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56496_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D. C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843\u2013850 (2011).","journal-title":"Science"},{"key":"56496_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"56496_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"56496_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature13764","volume":"516","author":"L Pappas","year":"2014","unstructured":"Pappas, L. et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516, 418\u2013422 (2014).","journal-title":"Nature"},{"key":"56496_CR27","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4049\/jimmunol.1402835","volume":"195","author":"AK Wheatley","year":"2015","unstructured":"Wheatley, A. K. et al. H5N1 vaccine-elicited memory B cells are genetically constrained by the IGHV locus in the recognition of a neutralizing epitope in the hemagglutinin stem. J. Immunol. 195, 602\u2013610 (2015).","journal-title":"J. Immunol."},{"key":"56496_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","volume":"166","author":"MG Joyce","year":"2016","unstructured":"Joyce, M. G. et al. Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses. Cell 166, 609\u2013623 (2016).","journal-title":"Cell"},{"key":"56496_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.chom.2020.06.003","volume":"28","author":"NC Wu","year":"2020","unstructured":"Wu, N. C. et al. Convergent evolution in breadth of two VH6-1-encoded influenza antibody clonotypes from a single donor. Cell Host Microbe 28, 434\u2013444.e4 (2020).","journal-title":"Cell Host Microbe"},{"key":"56496_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.chom.2018.09.010","volume":"24","author":"NC Wu","year":"2018","unstructured":"Wu, N. C. et al. Recurring and adaptable binding motifs in broadly neutralizing antibodies to influenza virus are encoded on the D3-9 segment of the Ig gene. Cell Host Microbe 24, 569\u2013578.e4 (2018).","journal-title":"Cell Host Microbe"},{"key":"56496_CR31","doi-asserted-by":"publisher","first-page":"13133","DOI":"10.1073\/pnas.1414070111","volume":"111","author":"AH Ellebedy","year":"2014","unstructured":"Ellebedy, A. H. et al. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc. Natl Acad. Sci. USA 111, 13133\u201313138 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56496_CR32","doi-asserted-by":"publisher","first-page":"e1000796","DOI":"10.1371\/journal.ppat.1000796","volume":"6","author":"TT Wang","year":"2010","unstructured":"Wang, T. T. et al. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog. 6, e1000796 (2010).","journal-title":"PLoS Pathog."},{"key":"56496_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aan2676","volume":"2","author":"SF Andrews","year":"2017","unstructured":"Andrews, S. F. et al. Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans. Sci. Immunol. 2, eaan2676 (2017).","journal-title":"Sci. Immunol."},{"key":"56496_CR34","doi-asserted-by":"publisher","first-page":"eabg4535","DOI":"10.1126\/scitranslmed.abg4535","volume":"13","author":"JJ Guthmiller","year":"2021","unstructured":"Guthmiller, J. J. et al. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Sci. Transl. Med 13, eabg4535 (2021).","journal-title":"Sci. Transl. Med"},{"key":"56496_CR35","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm.3927","volume":"21","author":"HM Yassine","year":"2015","unstructured":"Yassine, H. M. et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat. Med 21, 1065\u20131070 (2015).","journal-title":"Nat. Med"},{"key":"56496_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41586-021-04356-8","volume":"602","author":"JJ Guthmiller","year":"2022","unstructured":"Guthmiller, J. J. et al. Broadly neutralizing antibodies target a haemagglutinin anchor epitope. Nature 602, 314\u2013320 (2022).","journal-title":"Nature"},{"key":"56496_CR37","doi-asserted-by":"publisher","first-page":"316ra192","DOI":"10.1126\/scitranslmed.aad0522","volume":"7","author":"SF Andrews","year":"2015","unstructured":"Andrews, S. F. et al. Immune history profoundly affects broadly protective B cell responses to influenza. Sci. Transl. Med 7, 316ra192 (2015).","journal-title":"Sci. Transl. Med"},{"key":"56496_CR38","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1073\/pnas.1118979109","volume":"109","author":"GM Li","year":"2012","unstructured":"Li, G. M. et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl Acad. Sci. USA 109, 9047\u20139052 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56496_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade4976","volume":"15","author":"SF Andrews","year":"2023","unstructured":"Andrews, S. F. et al. An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans. Sci. Transl. Med 15, eade4976 (2023).","journal-title":"Sci. Transl. Med"},{"key":"56496_CR40","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.1073\/pnas.1810927115","volume":"115","author":"DJ Benton","year":"2018","unstructured":"Benton, D. J. et al. Influenza hemagglutinin membrane anchor. Proc. Natl Acad. Sci. USA 115, 10112\u201310117 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56496_CR41","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz, J. et al. The FoldX web server: an online force field. Nucleic Acids Res 33, W382\u2013W388 (2005).","journal-title":"Nucleic Acids Res"},{"key":"56496_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/14760584.2016.1203261","volume":"15","author":"LM Dunkle","year":"2016","unstructured":"Dunkle, L. M. & Izikson, R. Recombinant hemagglutinin influenza vaccine provides broader spectrum protection. Expert Rev. Vaccines 15, 957\u2013966 (2016).","journal-title":"Expert Rev. Vaccines"},{"key":"56496_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","volume":"37","author":"MM Cox","year":"2009","unstructured":"Cox, M. M. & Hollister, J. R. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals 37, 182\u2013189 (2009).","journal-title":"Biologicals"},{"key":"56496_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.coi.2018.04.009","volume":"53","author":"SF Andrews","year":"2018","unstructured":"Andrews, S. F. & McDermott, A. B. Shaping a universally broad antibody response to influenza amidst a variable immunoglobulin landscape. Curr. Opin. Immunol. 53, 96\u2013101 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"56496_CR45","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.immuni.2019.09.001","volume":"51","author":"M Sangesland","year":"2019","unstructured":"Sangesland, M. et al. Germline-encoded affinity for cognate antigen enables vaccine amplification of a human broadly neutralizing response against influenza virus. Immunity 51, 735\u2013749.e8 (2019).","journal-title":"Immunity"},{"key":"56496_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.1566","volume":"16","author":"J Sui","year":"2009","unstructured":"Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265\u2013273 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"56496_CR47","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.celrep.2017.08.084","volume":"20","author":"S Lang","year":"2017","unstructured":"Lang, S. et al. Antibody 27F3 broadly targets influenza A group 1 and 2 hemagglutinins through a further variation in VH1-69 antibody orientation on the HA stem. Cell Rep. 20, 2935\u20132943 (2017).","journal-title":"Cell Rep."},{"key":"56496_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8708","volume":"6","author":"Y Wu","year":"2015","unstructured":"Wu, Y. et al. A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nat. Commun. 6, 7708 (2015).","journal-title":"Nat. Commun."},{"key":"56496_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12780","volume":"7","author":"Y Fu","year":"2016","unstructured":"Fu, Y. et al. A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve. Nat. Commun. 7, 12780 (2016).","journal-title":"Nat. Commun."},{"key":"56496_CR50","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","volume":"166","author":"NL Kallewaard","year":"2016","unstructured":"Kallewaard, N. L. et al. Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166, 596\u2013608 (2016).","journal-title":"Cell"},{"key":"56496_CR51","doi-asserted-by":"publisher","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","volume":"3","author":"M Throsby","year":"2008","unstructured":"Throsby, M. et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3, e3942 (2008).","journal-title":"PLoS One"},{"key":"56496_CR52","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s42003-022-03700-6","volume":"5","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron. Commun. Biol. 5, 766 (2022).","journal-title":"Commun. Biol."},{"key":"56496_CR53","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cell.2015.05.007","volume":"161","author":"T Zhou","year":"2015","unstructured":"Zhou, T. et al. Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors. Cell 161, 1280\u20131292 (2015).","journal-title":"Cell"},{"key":"56496_CR54","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1021\/acscentsci.8b00666","volume":"4","author":"RE Amaro","year":"2018","unstructured":"Amaro, R. E. et al. A computational assay that explores the hemagglutinin\/neuraminidase functional balance reveals the neuraminidase secondary site as a novel anti-influenza target. ACS Cent. Sci. 4, 1570\u20131577 (2018).","journal-title":"ACS Cent. Sci."},{"key":"56496_CR55","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.aaz5143","volume":"368","author":"NC Wu","year":"2020","unstructured":"Wu, N. C. et al. Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses. Science 368, 1335\u20131340 (2020).","journal-title":"Science"},{"key":"56496_CR56","doi-asserted-by":"publisher","first-page":"e1005702","DOI":"10.1371\/journal.ppat.1005702","volume":"12","author":"N Chai","year":"2016","unstructured":"Chai, N. et al. Two escape mechanisms of influenza A virus to a broadly neutralizing stalk-binding antibody. PLoS Pathog. 12, e1005702 (2016).","journal-title":"PLoS Pathog."},{"key":"56496_CR57","doi-asserted-by":"publisher","first-page":"e03617","DOI":"10.1128\/mBio.03617-20","volume":"12","author":"EK Roubidoux","year":"2021","unstructured":"Roubidoux, E. K. et al. Mutations in the hemagglutinin stalk domain do not permit escape from a protective, stalk-based vaccine-induced immune response in the mouse model. mBio 12, e03617\u2013e03620 (2021).","journal-title":"mBio"},{"key":"56496_CR58","doi-asserted-by":"publisher","first-page":"e01639","DOI":"10.1128\/JVI.01639-18","volume":"93","author":"KL Prachanronarong","year":"2019","unstructured":"Prachanronarong, K. L. et al. Mutations in influenza A virus neuraminidase and hemagglutinin confer resistance against a broadly neutralizing hemagglutinin stem antibody. J. Virol. 93, e01639\u201318 (2019).","journal-title":"J. Virol."},{"key":"56496_CR59","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.1124513","volume":"312","author":"J Stevens","year":"2006","unstructured":"Stevens, J. et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312, 404\u2013410 (2006).","journal-title":"Science"},{"key":"56496_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"56496_CR61","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl Crystallogr 40, 658\u2013674 (2007).","journal-title":"J. Appl Crystallogr"},{"key":"56496_CR62","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"56496_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr D. Biol. Crystallogr 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"56496_CR64","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"56496_CR65","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1107\/S0021889883010985","volume":"16","author":"ML Connolly","year":"1983","unstructured":"Connolly, M. L. Analytical molecular surface calculation. J. Appl Crystallogr 16, 548\u2013558 (1983).","journal-title":"J. Appl Crystallogr"},{"key":"56496_CR66","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"56496_CR67","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s42003-023-04927-7","volume":"6","author":"B Abanades","year":"2023","unstructured":"Abanades, B. et al. ImmuneBuilder: Deep-Learning models for predicting the structures of immune proteins. Commun. Biol. 6, 575 (2023).","journal-title":"Commun. Biol."},{"key":"56496_CR68","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"56496_CR69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D. Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"56496_CR70","unstructured":"Kabat, E. A., Wu, T. T., Bilofsky, H. & National Institutes of, H. Sequences of immunoglobulin chains: tabulation and analysis of amino acid sequences of precursors, V-regions, C-regions, J-chain and \u03b22-microglobulins, 1979, xv, 185 p. (U. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, Bethesda, Md., 1979)."},{"key":"56496_CR71","doi-asserted-by":"publisher","first-page":"W34","DOI":"10.1093\/nar\/gkt382","volume":"41","author":"J Ye","year":"2013","unstructured":"Ye, J., Ma, N., Madden, T. L. & Ostell, J. M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res 41, W34\u2013W40 (2013).","journal-title":"Nucleic Acids Res"},{"key":"56496_CR72","doi-asserted-by":"publisher","first-page":"D1006","DOI":"10.1093\/nar\/gkn838","volume":"37","author":"MP Lefranc","year":"2009","unstructured":"Lefranc, M. P. et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 37, D1006\u2013D1012 (2009).","journal-title":"Nucleic Acids Res"},{"key":"56496_CR73","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jmb.2016.08.019","volume":"429","author":"MB Swindells","year":"2017","unstructured":"Swindells, M. B. et al. abYsis: integrated antibody sequence and structure-management, analysis, and prediction. J. Mol. Biol. 429, 356\u2013364 (2017).","journal-title":"J. Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56496-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56496-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T06:28:35Z","timestamp":1738477715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56496-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,2]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56496"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56496-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,2]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests. Florian Krammer is listed as a co-inventor on patent applications filed by The Icahn School of Medicine at Mount Sinai relating to SARS-CoV-2 serological assays, NDV-based SARS-CoV-2 vaccines, influenza virus vaccines, and influenza virus therapeutics. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2 and another company, Castlevax, to develop SARS-CoV-2 vaccines. Florian Krammer is a co-founder and scientific advisory board member of Castlevax. Florian Krammer has consulted for Merck, CureVac, Seqirus, GSK, and Pfizer and is currently consulting for 3rd Rock Ventures, Sanofi, Gritstone and Avimex. The Krammer laboratory is also collaborating with Dynavax on influenza vaccine development. Patrick Wilson and Jenna Guthmiller are listed as co-inventors on a patent application filed by the University of Chicago relating to anchor epitope targeting antibodies. The remaining Authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1268"}}